Geist MJP - Search Results

1

In Vivo CYP3A Activity in Palliative Care Patients: Study Protocol for a Single Arm Prospective Trial.

Geist MJP, Bardenheuer HJ, Burhenne J, Mikus G. Geist MJP, et al. J Palliat Med. 2018 May;21(5):686-688. doi: 10.1089/jpm.2017.0461. Epub 2018 Jan 12. J Palliat Med. 2018. PMID: 29327978

2

Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapies.

Geist MJP, Siller N, Egerer G, Bardenheuer H, Burhenne J, Mikus G. Geist MJP, et al. Basic Clin Pharmacol Toxicol. 2019 Aug;125(2):117-122. doi: 10.1111/bcpt.13232. Epub 2019 Apr 15. Basic Clin Pharmacol Toxicol. 2019. PMID: 30916851 Free article. Clinical Trial.

3

Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3A.

Geist M, Bardenheuer H, Burhenne J, Mikus G. Geist M, et al. Palliat Med. 2019 Jul;33(7):850-855. doi: 10.1177/0269216319843629. Epub 2019 Apr 26. Palliat Med. 2019. PMID: 31023150

4

Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients.

Geist MJP, Ziesenitz VC, Bardenheuer HJ, Burhenne J, Skopp G, Mikus G. Geist MJP, et al. Sci Rep. 2019 Oct 10;9(1):14635. doi: 10.1038/s41598-019-51279-6. Sci Rep. 2019. PMID: 31601999 Free PMC article. Clinical Trial.

5

Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid.

Geist MJP, Kessler J, Frankenhauser S, Bardenheuer HJ. Geist MJP, et al. J Palliat Care. 2017 Apr;32(2):47-48. doi: 10.1177/0825859717731701. Epub 2017 Sep 18. J Palliat Care. 2017. PMID: 28920517

6

[Potential of specialized outpatient palliative care].

Geist MJP, Bardenheuer HJ, Weigand MA, Frankenhauser S, Kessler J. Geist MJP, et al. Urologe A. 2018 May;57(5):563-567. doi: 10.1007/s00120-018-0571-0. Urologe A. 2018. PMID: 29374290 Review. German.

7

Steady-state pharmacokinetics and metabolism of voriconazole in patients.

Geist MJ, Egerer G, Burhenne J, Riedel KD, Weiss J, Mikus G. Geist MJ, et al. J Antimicrob Chemother. 2013 Nov;68(11):2592-9. doi: 10.1093/jac/dkt229. Epub 2013 Jun 13. J Antimicrob Chemother. 2013. PMID: 23766489

8

Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions.

Geist MJP, Egerer G, Mikus G, Blank A, Hohmann N, Heinz WJ, Carls A. Geist MJP, et al. Basic Clin Pharmacol Toxicol. 2019 Jan;124(1):56-61. doi: 10.1111/bcpt.13093. Epub 2018 Aug 2. Basic Clin Pharmacol Toxicol. 2019. PMID: 29989301 Free article.

9

[Interprofessional symptom management at the end of life].

Frankenhauser S, Geist MJP, Weigand MA, Bardenheuer HJ, Keßler J. Frankenhauser S, et al. Among authors: geist mjp. Urologe A. 2018 May;57(5):609-620. doi: 10.1007/s00120-018-0647-x. Urologe A. 2018. PMID: 29691593 German.

10

[Interprofessional symptom management at the end of life].

Frankenhauser S, Geist MJP, Weigand MA, Bardenheuer HJ, Keßler J. Frankenhauser S, et al. Among authors: geist mjp. Anaesthesist. 2017 Nov;66(11):889-900. doi: 10.1007/s00101-017-0377-2. Anaesthesist. 2017. PMID: 29030648 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters